Create Alert
Watchlist

Divi's Laboratories

3665.00
-103.00 (2.73%) 1D
NSE
1D
1W
1M
1Y
3Y
5Y
All

Performance

Open
3,778.20
Prev. Close
3,768.00
Volume
3,47,090
Total traded value
127 Cr
Upper Circuit
4,144.80
Lower Circuit
3,391.20

Market Depth

Buy order quantity
Sell order quantity
%
%
Loading...
Bid Total
131
Loading...
Ask Total
0

Analyst Estimates

63%
Buy
21%
Hold
16%
Sell
63%
Aggregated by Refinitiv from 19 Analysts

Fundamentals

Market Cap₹97,264Cr
ROE14.29%
P/E Ratio(TTM)65.84
EPS(TTM)55.65
P/B Ratio7.62
Dividend Yield0.82%
Industry P/E31.91
Book Value480.93
Debt to Equity0.00
Face Value2
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Divi's Labs

Divi's Laboratories Limited is an India-based company, which is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients with predominance in exports. The Company’s products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl and Vigabatrin. In addition to generic business, the Company, through its custom synthesis business, supports pharma companies for their patented products business right from gram scale requirements for clinical trials to launch, as well as late life cycle management. The Company’s subsidiaries include Divis Laboratories (USA) Inc. and Divi’s Laboratories Europe AG.;
Parent OrganisationDivi's Laboratories Limited
Founded1990
Managing DirectorDr. Murali Divi
NSE SymbolDIVISLAB

Shareholding Pattern

Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Promoters
51.93%
Foreign Institutions
14.69%
Mutual Funds
13.20%
Retail And Others
13.15%
Other Domestic Institutions
7.03%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Syngene International
₹770.05
(+0.18%)
64.71
Tarsons Products
NA
(0.00%)
31.63
Dishman Carbogen Amcis
NA
(0.00%)
NA
Suven Life Sciences
NA
(0.00%)
NA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.3.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ

ABOUT GROWW